Cargando…

Is It Possible to Predict Respiratory Evolution in COVID-19 Patients?

Detalles Bibliográficos
Autores principales:	Barbas, Carmen Silvia Valente, Mazza, Bruno Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254280/ https://www.ncbi.nlm.nih.gov/pubmed/35580562 http://dx.doi.org/10.1159/000524043

Ejemplares similares

Prone position failure in moderate-severe acute respiratory distress syndrome: and now?
por: Barbas, Carmen Silvia Valente, et al.
Publicado: (2023)

Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19
por: Del Vecchio, Lucia, et al.
Publicado: (2020)

Offline: After COVID-19—is an “alternate society” possible?
por: Horton, Richard
Publicado: (2020)

Elimination of COVID-19: what would it look like and is it possible?
por: Heywood, Anita E, et al.
Publicado: (2020)

Non-invasive respiratory support strategies in COVID-19
por: Gorman, Ellen, et al.
Publicado: (2021)

COVID-19 drug practices risk antimicrobial resistance evolution
por: Afshinnekoo, Ebrahim, et al.
Publicado: (2021)

Do endotracheal tubes with suction above the cuff decrease the rate of ventilator-associated pneumonia, and are they cost-effective?
por: Barbas, Carmen Sílvia Valente, et al.
Publicado: (2012)

Identification of pathophysiological patterns for triage and respiratory support in COVID-19
por: Camporota, Luigi, et al.
Publicado: (2020)

COVID-19: Respiratory support outside the intensive care unit
por: McEnery, Tom, et al.
Publicado: (2020)

Thoracic Computed Tomography to Assess ARDS and COVID-19 Lungs
por: Barbas, Carmen Silvia Valente
Publicado: (2022)

Treatment for severe acute respiratory distress syndrome from COVID-19
por: Matthay, Michael A, et al.
Publicado: (2020)

Management of Respiratory Failure Caused by COVID-19 after Thoracoscopic Esophagectomy
por: Takeda, Flavio Roberto, et al.
Publicado: (2021)

A nomogram for use of non-invasive respiratory strategies in COVID-19
por: Hess, Dean R
Publicado: (2021)

Respiratory support before venovenous ECMO for COVID-19: what is the price?
por: Giani, Marco, et al.
Publicado: (2023)

Single-Breath Counting Test to Start Non-Invasive Respiratory Support in COVID-19 Patients: Early Detection and the Eternal Dilemma. Comment on Longhitano et al. Single-Breath Counting Test Predicts Non-Invasive Respiratory Support Requirements in Patients with COVID-19 Pneumonia. J. Clin. Med. 2022, 11, 179
por: Oldani, Stefano, et al.
Publicado: (2022)

COVID-19 Close Contact Management: An Evolution of Operations Harnessing the Digital Edge
por: Seah, Benjamin ZQ, et al.
Publicado: (2023)

Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance
por: Merenstein, Carter, et al.
Publicado: (2022)

Physiological and biological heterogeneity in COVID-19-associated acute respiratory distress syndrome
por: Ware, Lorraine B
Publicado: (2020)

Increasing our ability to predict contemporary evolution
por: Nosil, Patrik, et al.
Publicado: (2020)

COVID-19-related acute respiratory distress syndrome: lessons learned during the pandemic
por: Schultz, Marcus J, et al.
Publicado: (2022)

The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada
por: Maharaj, Arjuna S, et al.
Publicado: (2021)

Acute Respiratory Infections
Publicado: (1918)

The quintuple penalty of obese patients in the COVID-19 pandemic
por: Slim, Karem, et al.
Publicado: (2020)

Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms
por: Pain, Clare E, et al.
Publicado: (2020)

Arrhythmias in COVID-19. Do they influence outcomes in hospitalized patients?
por: Oliveira, Mário
Publicado: (2021)

Arrhythmias in COVID-19. Do they influence outcomes in hospitalized patients?
por: Oliveira, Mário
Publicado: (2021)

Clinical Findings, Treatment and Prognosis in Patients with Severe Acute Respiratory Syndrome (SARS)
por: Chang, Shan-Chwen
Publicado: (2005)

Empagliflozin and HFrEF: Known and Possible Benefits of NHE1 Inhibition
por: Jun, Seungho, et al.
Publicado: (2019)

An immunometabolic signature of athletes susceptible to respiratory tract illness? Comment on: Evidence of immunometabolic dysregulation and airway dysbiosis in athletes susceptible to respiratory illness
por: Gualano, Bruno, et al.
Publicado: (2022)

Prediction models for COVID-19 clinical decision making
por: Leeuwenberg, Artuur M, et al.
Publicado: (2020)

Applications of predictive modelling early in the COVID-19 epidemic
por: Poletto, Chiara, et al.
Publicado: (2020)

A negative trial for vasoactive intestinal peptide in COVID-19-associated acute hypoxaemic respiratory failure
por: Lee, Warren L, et al.
Publicado: (2023)

Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?
por: Karadağ, Bilgehan
Publicado: (2020)

Commentary: Increased Risk of Cardiovascular Disease in Restless Legs Syndrome Patients: A Call to Action
por: De Berardis, Domenico, et al.
Publicado: (2023)

Myocardial performance index: Is it time to revisit this old parameter in COVID-19 patients?
por: Timóteo, Ana Teresa
Publicado: (2022)

Comment on: Prior bariatric surgery in COVID-19 positive patients may be protective
por: Altieri, Maria S.
Publicado: (2021)

Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
por: Pickles, Oliver J., et al.
Publicado: (2020)

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

COVID-19 sequelae: can long-term effects be predicted?
por: Gavriilaki, Eleni, et al.
Publicado: (2022)

Improving clinical management of COVID-19: the role of prediction models
por: Wynants, Laure, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pi449svanvj815gdep6gaqe058